News
Twist Bioscience ( NASDAQ: TWST) and Ginkgo Bioworks ( NYSE: DNA) said on Thursday that they have updated a previous ...
Q1 2025 Management View CEO Jason Kelly highlighted the progress made on cost reduction, achieving a $205 million annualized cost cut as of Q1 2025. This exceeds the original $200 million target set ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback